Marta Maschio

Medicine & Life Sciences

1. Brain Neoplasms 100%
2. Epilepsy 97%
3. Seizures 50%
4. Anticonvulsants 48%
5. Electroencephalography 29%
6. Lacosamide 28%
7. Glioma 28%
8. perampanel 21%
9. Oxcarbazepine 18%
10. Levetiracetam 18%
11. Partial Epilepsy 17%
12. Therapeutics 16%
13. Quality of Life 14%
14. Zonisamide 14%
15. Temozolomide 11%
16. brivaracetam 11%
17. Carbamazepine 10%
18. Mental Processes 10%
19. Lamotrigine 9%
20. Bevacizumab 9%
21. Sleep 9%
22. Topiramate 9%
23. Drug Therapy 9%
24. Preliminary Data 8%
25. Observational Studies 7%
26. Temporal Lobe Epilepsy 7%
27. Glioblastoma 7%
28. Idiopathic Generalized Epilepsy 7%
29. fotemustine 7%
30. Pharmaceutical Preparations 7%
31. Pregabalin 7%
32. Brain 6%
33. Sleepiness 6%
34. Prospective Studies 6%
35. Radiotherapy 6%
36. Multiple Myeloma 6%
37. Cohort Studies 6%
38. Vigabatrin 5%
39. Monoclonal Gammopathy of Undetermined Significance 5%
40. Neoplasm Metastasis 5%
41. Rehabilitation 5%
42. Evaluation Studies 5%
43. Population 5%
44. Thioctic Acid 5%
45. Neoplasms 5%
46. Bortezomib 5%
47. Eye 5%
48. Valproic Acid 5%
49. Spastic paraplegia epilepsy mental retardation 5%
50. Safety 5%